CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 62 filers reported holding CYTOSORBENTS CORP in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,180 | -47.6% | 23,500 | 0.0% | 0.01% | -42.1% |
| Q2 2023 | $84,365 | +25.2% | 23,500 | +17.5% | 0.02% | +18.8% |
| Q1 2023 | $67,400 | +117.4% | 20,000 | 0.0% | 0.02% | +100.0% |
| Q4 2022 | $31,000 | +106.7% | 20,000 | +81.8% | 0.01% | +100.0% |
| Q3 2022 | $15,000 | -37.5% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -31.4% | 11,000 | +175.0% | 0.00% | -42.9% |
| Q1 2021 | $35,000 | -37.5% | 4,000 | -42.9% | 0.01% | -46.2% |
| Q4 2020 | $56,000 | 0.0% | 7,000 | 0.0% | 0.01% | -7.1% |
| Q3 2020 | $56,000 | -18.8% | 7,000 | 0.0% | 0.01% | -46.2% |
| Q2 2020 | $69,000 | +27.8% | 7,000 | 0.0% | 0.03% | +8.3% |
| Q1 2020 | $54,000 | – | 7,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $1,616 | 1.58% |
| Skylands Capital, LLC | 2,793,470 | $10,028,557 | 1.44% |
| Sargent Investment Group, LLC | 1,289,546 | $4,629,470 | 1.12% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 237,940 | $854,205 | 0.96% |
| Avenir Corp | 2,719,732 | $9,763,838 | 0.86% |
| Granahan Investment Management | 1,616,587 | $5,803,547 | 0.18% |
| Seelaus Asset Management LLC | 20,450 | $73 | 0.06% |
| Cowen Prime Advisors LLC | 42,301 | $151,861 | 0.05% |
| HighMark Wealth Management LLC | 10,000 | $35,900 | 0.03% |
| Key Client Fiduciary Advisors, LLC | 12,000 | $43,080 | 0.02% |